1. Prior administration of an investigational coronavirus (SARS-CoV, MERS-CoV) vaccine or current/planned simultaneous participation in another interventional study to either prevent or treat COVID-19 2. Participant has a contraindication to blood draws (eg, bleeding disorders) 3. Has participated in an interventional clinical study within 30 days prior to study inclusion

1. Prior administration of an investigational coronavirus (SARS-CoV, MERS-CoV) vaccine or current/planned simultaneous participation in another interventional study to either prevent or treat COVID-19 2. Participant has a contraindication to blood draws (eg, bleeding disorders) 3. Has participated in an interventional clinical study within 30 days prior to study inclusion